UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000007180
Receipt No. R000007139
Scientific Title A phase II neoadjuvant trial of sequential tri-weekly nanoparticle albumin-bound paclitaxel (Abraxane)/cyclophosphamide, with trastuzumab in HER2-positive patients, followed by 5-fluorouracil/epirubicine/cyclophosphamide (FEC) in operable breast cancer
Date of disclosure of the study information 2012/02/01
Last modified on 2015/08/18 08:20:08

No. Disposal Last modified on Item of update
1 Insert 2012/01/31 15:58:30
2 Update 2014/07/31 12:36:38 Recruitment status
3 Update 2015/08/18 08:12:26 Recruitment status
4 Update 2015/08/18 08:14:00 Publication of results
URL related to results and publications
5 Update 2015/08/18 08:15:00 Key inclusion criteria
6 Update 2015/08/18 08:20:08 Email
Email


Contact us.